Aclarubicin

DRUG7 trials

Sponsors

Washington University School of Medicine, Shandong University, Sun Yat-sen University, Shanghai Jiao Tong University School of Medicine

Conditions

Acute Myeloid LeukemiaAcute Myeloid Leukemia (AML)Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative)Cerebroretinal Vasculopathy, HereditaryCutaneous T Cell Lymphoma (CTCL)Cutaneous T-Cell Lymphoma RefractoryCutaneous T-Cell Lymphoma, RelapsedElderly Patients

Phase 1

Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy

CompletedNCT02723448

Washington University School of MedicineCerebroretinal Vasculopathy, Hereditary, Vasculopathy, Retinal, With Cerebral Leukodystrophy

Start: 2016-12-05End: 2020-07-23Updated: 2020-11-19

Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia

Not yet recruitingNCT07486726

Shanghai Jiao Tong University School of MedicineAcute Myeloid Leukemia (AML), Refractory Acute Myeloid Leukemia (AML), Relapse Acute Myeloid Leukemia

Start: 2026-03-15End: 2028-10-01Target: 112Updated: 2026-03-20

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma

Not yet recruitingNCT07535710

Shanghai Jiao Tong University School of MedicineCutaneous T Cell Lymphoma (CTCL), Cutaneous T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma, Relapsed +1

Start: 2026-03-30End: 2028-12-31Target: 37Updated: 2026-04-17

Phase 2

Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients

Shandong UniversityAcute Myeloid Leukemia

Start: 2017-01-31End: 2020-07-31Target: 120Updated: 2017-02-07

Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia

Sun Yat-sen UniversityAcute Myeloid Leukemia, Relapse Leukemia

Start: 2016-01-01End: 2019-12-31Target: 48Updated: 2019-08-20

Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML

Sun Yat-sen UniversityAcute Myeloid Leukemia, Elderly Patients, Newly Diagnosed

Start: 2021-03-01End: 2023-12-31Target: 34Updated: 2020-12-17

Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma

Not yet recruitingNCT07535762

Shanghai Jiao Tong University School of MedicineAnaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative), Nodal T-follicular Helper Cell Lymphoma, Peripheral T-Cell Lymphoma (PTCL NOS)

Start: 2026-03-30End: 2028-12-30Target: 36Updated: 2026-04-17